[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level

Xu,Zongquan; Chen,Yu; Xu,Guohui; Peng,Cheng; Liu,Enyu; Li,Yunguang; Niu,Jun; Li,Changhai

doi:10.3892/or.2024.8804

November-2024 Volume 52 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2024 Volume 52 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level

Authors:
- Zongquan Xu
- Yu Chen
- Guohui Xu
- Cheng Peng
- Enyu Liu
- Yunguang Li
- Jun Niu
- Changhai Li
View Affiliations / Copyright

Affiliations: Deparment of Hepatic Oncology, Jiangxi Provincial Cancer Hospital, Nanchang, Jiangxi 330029, P.R. China, Department of Hepatobiliary Surgery, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Hepatic Surgery Center Affiliated Tongji Hospital, Tongji Medical College of HuaZhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China

Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 145
|
Published online on: August 28, 2024

https://doi.org/10.3892/or.2024.8804
Expand metrics +

Article

Oncol Rep 33: [Related article:] 905–912, 2015; DOI: 10.3892/or.2014.3656

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that the control western blots shown for Fig. 1A and B on p. 908 and Fig. 8A and C on p. 911 were apparently the same, where different experiments were intended to have been portrayed.

Figure 1.

Omi/HtrA2 mRNA and protein expression in HepG2 transfected with Omi/HtrA2 expression vector pEGFP-Omi or Omi/HtrA2 small interference RNA expression vector psiRNA-Omi

Figure 8.

Protein expression of XIAP, ped/pea-15 (PEA-15) and HAX-1 in HepG2, Hep3B and PLC cells. XIAP overexpressed in HepG2, Hep3B and PLC cells and its expression had no difference among them and HepG2, Hep3B and PLC cells had no HAX-1 expression. (A) PLC cells were devoid of ped/pea-15 expression although ped/pea-15 was overexpressed in HepG2 and Hep3B cells. However, ped/pea-15 expression was higher in HepG2 cells than that in Hep3B cells. (B) The protein expression of XIAP and HAX-1 in HepG2, Hep3B and PLC cells showed no change, whereas ped/pea-15 protein expression increased in HepG2 and Hep3B cells following cell exposure to ucf-101. (C) The protein expression of XIAP and HAX-1 in HepG2, Hep3B and PLC cells did not change, whereas the ped/pea-15 protein expression decreased in HepG2 and Hep3B cells when cells were transfected into pEGFP-Omi. (D) The change of ped/pea-15 protein expression in HepG2 cells was more evident than that in Hep3B cells when transfected into pEGFP-Omi or exposed to ucf-101.

After having re-examined their original data files, the authors realized that these figures had been published with the control western blots shown incorrectly for Fig. 1A and 8C. The corrected versions of this pair of figures are shown on the next page. Note that the corrections made to these figures do not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level

This article is mentioned in:

Article

Figure 1.

Figure 8.

Related Articles